News
The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...
CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on Novo Nordisk, what new FDA approval on its ...
Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s ...
Approval of an injectable monoclonal antibody offers an easier delivery option and could broaden use of the COVID preventive.
Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...
A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...
By Lori Solomon HealthDay ReporterMONDAY, Aug. 18, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
US regulators sent seemingly mixed messages this month about the outlook for animal-derived, or desiccated, thyroid medicines ...
Sublingual cyclobenzaprine (Tonmya), a nonopioid treatment for adults with fibromyalgia, targets nonrestorative sleep, a root ...
Tonmya is the first new fibromyalgia therapy approved in over 15 years, targeting nonrestorative sleep to alleviate core ...
The FDA’s recent issue of five warning letters to brands illegally marketing whipped, mousse and foam sunscreen products ...
A new study shows access to birth control has increased following the FDA's approval of an over-the-counter birth control pill. In the two years since the pill went on the market, there's a 31.8% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results